The latest price target for Crescent Capital BDC (NASDAQ:CCAP) was reported by Keefe, Bruyette & Woods on November 25, 2024. The analyst firm set a price target for $20.00 expecting CCAP to rise to within 12 months (a possible 2.46% upside). 10 analyst firms have reported ratings in the last year.

The latest analyst rating for Crescent Capital BDC (NASDAQ:CCAP) was provided by Keefe, Bruyette & Woods, and Crescent Capital BDC maintained their outperform rating.

The last upgrade for Crescent Capital BDC Inc happened on August 12, 2022 when Oppenheimer raised their price target to $19. Oppenheimer previously had a perform for Crescent Capital BDC Inc.

The last downgrade for Crescent Capital BDC Inc happened on November 13, 2023 when Wells Fargo changed their price target from $16.5 to $16 for Crescent Capital BDC Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Crescent Capital BDC, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Crescent Capital BDC was filed on November 25, 2024 so you should expect the next rating to be made available sometime around November 25, 2025.

While ratings are subjective and will change, the latest Crescent Capital BDC (CCAP) rating was a maintained with a price target of $19.00 to $20.00. The current price Crescent Capital BDC (CCAP) is trading at is $19.52, which is within the analyst’s predicted range.